StockNews.com Upgrades ProQR Therapeutics (NASDAQ:PRQR) to Buy
ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. ProQR Therapeutics Stock Performance NASDAQ PRQR opened at $2.05 on Monday. The firm’s fifty day moving average price is $2.07 and its two-hundred day moving average price […]
More Stories
Trump Admin Uses Emergency Powers to Clear $8.6 Billion Mideast Arms Sales
By Kimberly Hayek The Trump administration invoked emergency powers on May 1 to go around congressional review and approve more...
Congress Reacts to Redistricting Decision by Supreme Court
By Jackson Richman Members of Congress offered mixed reactions after the Supreme Court limited the use of race in redistricting,...
Spirit Airlines Shuts Down After Rescue Efforts Fall Short
By Tom Ozimek Budget carrier Spirit Airlines said Saturday it will halt all operations immediately, canceling all flights and beginning...
US to Release up to 92.5 Million Barrels of Oil From Reserves
By Naveen Athrappully The United States is considering releasing up to 92.5 million barrels of crude oil from its Strategic...
Pentagon Forges Partnership With Leading AI Companies
By Stacy Robinson The Pentagon has entered into an alliance with seven leading artificial intelligence (AI) companies, the Department of...
Chevron, Exxon Decline to Boost Oil Production Despite Trump Admin Requests
By Guy Birchall ExxonMobil and Chevron have said they won’t boost oil production despite the Trump administration’s calls for them...